In the last trading session, 14.19 million shares of the Third Harmonic Bio Inc (NASDAQ:THRD) were traded, and its beta was 2.70. Most recently the company’s share price was $3.25, and it changed around -$1.4 or -30.11% from the last close, which brings the market valuation of the company to $146.44M. THRD currently trades at a discount to its 52-week high of $16.94, offering almost -421.23% off that amount. The share price’s 52-week low was $4.57, which indicates that the current value has fallen by an impressive -40.62% since then. We note from Third Harmonic Bio Inc’s average daily trading volume that its 10-day average is 0.27 million shares, with the 3-month average coming to 245.40K.
Third Harmonic Bio Inc stock received a consensus recommendation rating of Buy, based on a mean score of 1.60. If we narrow it down even further, the data shows that 0 out of 7 analysts rate the stock as a Sell; another 2 rate it as Overweight. Among the rest, 2 recommended THRD as a Hold, whereas 3 deemed it a Buy, and 0 rated it as Underweight. Third Harmonic Bio Inc is expected to report earnings per share of -0.36 for the current quarter.
Third Harmonic Bio Inc (NASDAQ:THRD) trade information
Instantly THRD has showed a red trend with a performance of -30.11% at the end of last trading. The performance over the last five days has remained in the red territory. The rise to weekly highs of 5.28 on recent trading dayincreased the stock’s daily price by 38.45%. The company’s shares are currently down -68.42% year-to-date, but still down -33.67% over the last five days. On the other hand, Third Harmonic Bio Inc (NASDAQ:THRD) is -61.08% down in the 30-day period. We can see from the shorts that 3.57 million shares have been sold at a short interest cover period of 12.68 day(s).
The consensus price target as assigned by Wall Street analysts is $19, which translates to bulls needing to increase their stock price by 82.89% from its current value. Analyst projections state that THRD is forecast to be at a low of $3.6 and a high of $23.
Third Harmonic Bio Inc (NASDAQ:THRD)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 9.05% of Third Harmonic Bio Inc shares, and 93.98% of them are in the hands of institutional investors. The stock currently has a share float of 103.33%. Third Harmonic Bio Inc stock is held by 117.0 institutions, with ATLAS VENTURE LIFE SCIENCE ADVISORS, LLC being the largest institutional investor. By 2024-06-30, it held 26.8961% of the shares, which is about 10.91 million shares worth $141.8 million.
ORBIMED ADVISORS LLC, with 14.2498% or 5.78 million shares worth $75.13 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
Price (T.Rowe) Small-Cap Value Fund and Fidelity Select Portfolios – Health Care were the top two Mutual Funds as of Sep 30, 2024. The former held 846.79 shares worth $2.75 million, making up 1.88% of all outstanding shares. On the other hand, Fidelity Select Portfolios – Health Care held roughly 680.0 shares worth around $2.21 million, which represents about 1.51% of the total shares outstanding.
